January 2021
Fund Research
International Biotechnology

IBT offers a differentiated way to access strong growth prospects at an undemanding valuation...
October 2020
Events
Alternatives for Income Investors

Slides and audio from our event focused on alternative routes to a reliable income…
September 2020
Replay
Slides and Audio: International Biotechnology

View the presentation and listen to the audio from our 'Alternatives for Income Investors' event on 29 September...
July 2020
Fund Research
International Biotechnology

IBT offers a differentiated exposure to a secular growth theme complemented by a solid yield…
June 2020
Opinion
Selling the family silver

Is there something fishy about a trust paying dividends from capital?
February 2020
Head to Head
Robbing Peter to pay Paul?

Two of our analysts discuss the growing trend for companies to pay an income out of capital…
December 2019
Fund Research
International Biotechnology Trust

A highly experienced management team and a flexible portfolio of quoted and unquoted biotechnology stocks, with a yield target of 4% of NAV...
May 2019
Fund Research
International Biotechnology Trust

We discuss the opportunity as biotech stocks trade at record low valuations, despite strong prospects for the sector...
People
A steady hand

Chairman of International Biotechnology Trust, John Aston, explains how his unusual background in both biotechnology and banking come together on the trust...
April 2019
People
Art meets science

Carl Harald Janson explains how his experiences in science and business blend seamlessly in his management of International Biotechnology Trust...
October 2018
Fund Research
International Biotechnology Trust

Five years on from the appointment of a new manager, this US-focused biotech trust has seen its fortunes transformed...
August 2018
Strategy
Reassuringly expensive?

Some investment trust premiums have been stretched to eye-watering levels. Have investors been enjoying themselves in the sun too much? We try to rationalise current levels and suggest alternatives...
March 2018
Fund Research
International Biotechnology Trust

A well-resourced biotechnology fund that has produced annualised returns of +18% under the current manager, offering a yield of 4%...
Income
The search for discounted yield

We scour the investment trust universe for trusts offering chunky yields on a discount...
January 2018
Fund Research
The Income Diversifiers Conference

CPD certificate, speaker presentations and slides...
September 2017
Disruption
Winners and losers from tomorrow’s world

Searching for the Tesla of tomorrow…
Asset allocation
Not the usual suspects...

As equity valuations continue to defy logic, we identify the trusts least correlated to their fortunes...
Fund Research
International Biotechnology Trust

Proven alpha generation from a strong management team, low correlation to mainstream equities, and a yield of 4%...
June 2017
Fund managers
The doctor will see you now...

Carl Harald Janson, once dubbed 'the world's best biotech manager' by Bloomberg, tells us what he thinks lies in store for the sector...
February 2017
Strategy
Don't wanna be an American idiot

We highlight various routes to US exposure for those who are not sure how much faith they place in the 'Trump Bump'...
November 2016
Fund Research
International Biotechnology Trust
Strategy
Fortune favours the brave

Our analysis shows that technology trusts are far less risky than the returns they have generated suggest...

Welcome to Kepler Trust Intelligence

Kepler Trust Intelligence is authorised in the UK by the Financial Conduct Authority.
Please enter a valid email address
{{item.msg}}
Please enter a valid password
{{item.msg}}
Please enter a valid email address
{{item.msg}}
Please check your email. If an account exists you'll be sent instructions on how to reset your password.
Kepler Trust Intelligence is authorised in the UK by the Financial Conduct Authority. To ensure that we are able to provide content which is appropriate for you, please tell us a little about yourself.
Please choose an option
{{item.msg}}
Please enter a company name
{{item.msg}}
Please enter a location name
{{item.msg}}
Please choose an option
{{item.msg}}
Please enter a platform
{{item.msg}}
Please choose an option
{{item.msg}}
Please enter a trust
{{item.msg}}
?
The information contained herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States to or for the benefit of any United States person (being residents of the United States or partnerships or corporations organised under the laws thereof). The investment funds referred to herein have not been registered in the United States under the Investment Company Act of 1940 and units or shares of such funds are not registered in the United States under the Securities Act of 1933.
Please confirm
{{item.msg}}
Please select an option
{{item.msg}}
See benefits
A free Kepler Trust Intelligence account allows you to access premium content including the ‘Kepler View’ – our verdict on the trusts we cover – and historical research so you can see how our view has changed over time. An account also unlocks useful facilities like the ‘follow’ button which lets you keep track of the trusts you’re interested in and as a logged in user you can also download PDFs of our research, and choose the layout of the page you’re reading to suit your preference. We will not share your details unless you give us permission to do so, and we won’t bombard you with emails – we only send one a week.
Please select an option
{{item.msg}}
Please enter your first name
{{item.msg}}
Please enter your last name
{{item.msg}}
Please enter a valid email address
An account already exists with this email - have you forgotten your password?
{{item.msg}}
Please enter a valid password
{{item.msg}}
Please enter a valid password
{{item.msg}}
Already got an account?
How will this information be used? Your answers help us to tailor our content to relevant investment trusts, and to ensure that the asset allocation and portfolio strategy research we produce is appropriate to our userbase.
Our Website uses Cookies Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies, but parts of our site won’t work without them. By using our website you accept our use of cookies. For further information please refer to the Kepler Privacy Notice.
Need help?

One more thing...

Did you know, you can 'follow' individual trusts on Kepler Trust Intelligence? Use the functions below to set up alerts and we'll send you research and updates on your chosen trusts.

Suggested trusts to follow

{{item.name}} x
Browse all funds
Need help?
Current Site Kepler Trust Intelligence is produced by the investment companies team at Kepler Partners and is the UK’s premier source of detailed qualitative research on investment trusts. Absolute Hedge is a market leading UCITS research database providing proprietary research on funds, themes and strategies in the UCITS space. Kepler Liquid Strategies is a Dublin domiciled UCITS fund platform featuring a number of best-of-breed fund managers. Kepler Partners is a corporate advisory and asset raising boutique specialising in the regulated funds market in Europe and investment trusts in the UK.